Artificial Intelligence in Nanomedicine Formulation and Applications

Abstract

Artificial intelligence is emerging as a transformative factor in the development of nanomedicine—the integration of nanotechnology and biomedical science to solve complex health problems. This paper reports on the synergistic integration of AI and nanomedicine, with a focus on the contributions it makes towards creating nanoscale materials, upgrading nanomaterials, and applications in diagnostics, drug delivery, and regenerative therapy. AI-driven approaches rapidly identify the ideal properties of nanomaterials, enhance the interaction between drugs and nanoparticles, and improve the accuracy of their mechanism for targeting diseases. Here, predictive modeling using machine learning algorithms accelerates progress in nanocarriers, nanosensors, and imaging technologies, while providing an opportunity to detect diseases at early stages and customize targeted therapeutic strategies [1]. <br><br>The article highlights revolutionary breakthroughs enabled by AI in addressing the aforementioned limitations of nanomedicine, specifically in terms of production scales, regulatory burdens, and nano-material toxicity. Case studies illustrating AI-driven breakthroughs in treatments for cancer, cardiovascular diseases, and neurological disorders describe improved clinical results through targeted and advanced diagnostics and treatments. However, the convergence of AI and nanomedicine also raises ethical, regulatory, and data-related issues that require interdisciplinary collaboration and robust frameworks for responsible implementation. This study highlights the potential of AI in transforming nanomedicine, paving the way for next-generation medical solutions that are more secure, efficient, and tailored to meet the unique needs of patients. By connecting computational technologies with biomedical applications, the research envisions a future in which AI-driven nanomedicine revolutionizes healthcare delivery worldwide [2].

Ähnliche Arbeiten